169 related articles for article (PubMed ID: 20001475)
1. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.
Axelsson R; Bach-Gansmo T; Castell-Conesa J; McParland BJ;
Acta Radiol; 2010 Feb; 51(1):40-6. PubMed ID: 20001475
[TBL] [Abstract][Full Text] [Related]
2. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.
Bach-Gansmo T; Danielsson R; Saracco A; Wilczek B; Bogsrud TV; Fangberget A; Tangerud A; Tobin D
J Nucl Med; 2006 Sep; 47(9):1434-9. PubMed ID: 16954550
[TBL] [Abstract][Full Text] [Related]
3. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study.
Zhu Z; Miao W; Li Q; Dai H; Ma Q; Wang F; Yang A; Jia B; Jing X; Liu S; Shi J; Liu Z; Zhao Z; Wang F; Li F
J Nucl Med; 2012 May; 53(5):716-22. PubMed ID: 22499615
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Integrin α
Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
[TBL] [Abstract][Full Text] [Related]
6. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
Dearling JL; Barnes JW; Panigrahy D; Zimmerman RE; Fahey F; Treves ST; Morrison MS; Kieran MW; Packard AB
Nucl Med Biol; 2013 Aug; 40(6):788-94. PubMed ID: 23701702
[TBL] [Abstract][Full Text] [Related]
7. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 99mTc-3PRGD2 integrin receptor imaging with 99mTc-MDP bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study.
Miao W; Zheng S; Dai H; Wang F; Jin X; Zhu Z; Jia B
PLoS One; 2014; 9(10):e111221. PubMed ID: 25338281
[TBL] [Abstract][Full Text] [Related]
11. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Wang F; Wang Z; Yao W; Xie H; Xu J; Tian L
J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
[TBL] [Abstract][Full Text] [Related]
12. Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.
Sah BR; Schibli R; Waibel R; von Boehmer L; Bläuenstein P; Nexo E; Johayem A; Fischer E; Müller E; Soyka JD; Knuth AK; Haerle SK; Schubiger PA; Schaefer NG; Burger IA
J Nucl Med; 2014 Jan; 55(1):43-9. PubMed ID: 24337606
[TBL] [Abstract][Full Text] [Related]
13. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
16. Integrin Imaging with
Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
[TBL] [Abstract][Full Text] [Related]
17. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
Chen B; Zhao G; Ma Q; Ji B; Ji T; Xin H; Gao S
Int J Clin Exp Pathol; 2015; 8(12):16064-72. PubMed ID: 26884883
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
[TBL] [Abstract][Full Text] [Related]
19. [Detection of melanoma metastases with Tc-99m-tetrofosmin].
Rettenbacher L; Koller J; Kässmann H; Galvan G
Nuklearmedizin; 2000; 39(4):97-101. PubMed ID: 10919159
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]